Position Summary:

TScan is seeking an accomplished and strategic Vice President, Biostatistics to lead all biometric activities across the company's clinical development portfolio, including multiple ongoing and planned studies supporting the advancement of TCR-T cell therapies for patients with cancer. This executive leader will be responsible for defining and executing the statistical and biometrics strategy, ensuring scientific rigor, regulatory compliance, and operational excellence from first-in-human to late-stage development, including regulatory submission and commercialization.

As a key member of the Senior Leadership Team, the VP, Biostatistics will partner closely with Clinical Development, Clinical Operations, Regulatory Affairs, Data Sciences, Translational Medicine and Executive Leadership to drive successful development and registration strategies. The individual will serve as the primary statistical representative to regulatory authorities and external stakeholders, and will play a critical role in shaping the future of TScan's clinical development organization.

Responsibilities:

Strategic Leadership

• Establish and lead the biostatistics strategy across TScan's clinical development portfolio, from Phase 1 to registrational and post-registration studies.
• Provide statistical leadership and strategic guidance to executive management on development plans, clinical study design, endpoint selection, estimands, and data interpretation.
• Contribute to portfolio strategy, lifecycle management planning, and business development evaluations.
• Serve as a trusted advisor to senior leadership on benefit-risk assessments and key development decisions.

Clinical Development & Regulatory Strategy

• Lead statistical design and analysis planning for all clinical studies.
• Oversee development of protocols, statistical analysis plans (SAPs), clinical study reports (CSRs), integrated summaries, and regulatory submission documents.
• Drive statistical strategy for complex cell therapy clinical programs, including durability analyses, long-term follow-up, safety monitoring, and innovative endpoint development.
• Represent Biostatistics in interactions with FDA, EMA, and other global regulatory agencies.
• Provide leadership for regulatory submissions, including BLA and international marketing applications.
• Ensure all statistical deliverables are scientifically sound and aligned with global regulatory expectations.

Functional Leadership

• Build and lead a high-performing biostatistics organization.
• Oversee external CROs, statistical programming partners, and consultants to ensure quality, efficiency, and compliance.
• Establish and continuously improve departmental processes, standards, and quality systems.
• Foster a culture of scientific excellence, innovation, collaboration, and accountability.

Cross-Functional Collaboration

• Partner with Clinical Development to optimize study designs and interpret emerging clinical data.
• Collaborate closely with Data Management and Statistical Programming teams to ensure high-quality and timely analyses.
• Support Medical Affairs, Publications, and Investor Relations through statistical interpretation and communication of clinical results.
• Present statistical findings and strategic recommendations to senior leadership, Board members, and external stakeholders.

Requirements:

Education

• PhD in Biostatistics, Statistics, or a related quantitative discipline required.

Experience

• Minimum of 15 years of biostatistics experience in biotechnology, pharmaceutical, or related industries.
• Significant leadership experience managing biostatistics organizations in a clinical development environment.
• Demonstrated success leading statistical strategy for pivotal clinical trials and regulatory submissions.
• Experience supporting BLA, NDA, MAA, or equivalent regulatory filings.
• Experience in oncology and advanced therapies, including cell therapy, TCR-T, CAR-T, gene therapy, or immuno-oncology strongly preferred.
• Strong understanding of global regulatory requirements and evolving statistical expectations in advanced therapeutic modalities.

Technical Expertise

• Deep expertise in clinical trial design, survival analysis, longitudinal data analysis, multiplicity control, estimands, missing data methodologies, and adaptive designs.
• Strong knowledge of FDA, EMA, ICH, and CDISC standards.
• Experience overseeing statistical programming and integrated analyses.
• Familiarity with innovative trial designs and analytical approaches relevant to cellular therapies.

Leadership Competencies

• Strategic and enterprise-minded leader with strong business acumen.
• Excellent communication skills with the ability to influence diverse stakeholders.
• Proven ability to build and scale high-performing teams in a fast-paced biotechnology environment.
• Strong executive presence and ability to communicate complex statistical concepts to both technical and non-technical audiences.
• Collaborative leader who thrives in highly cross-functional organizations.

Pay Range: $340,000 - $380,000

Pay Transparency

TScan Therapeutics' pay ranges are established based on external market data from third-party compensation surveys and our internal benchmarking. This role is eligible for an annual bonus and annual equity awards. Some roles may also be eligible for overtime pay, in accordance with federal and state requirements. Individual compensation within this range is commensurate with a candidate's specific qualifications, including education, overall experience, relevant experience, and specific skills. We strive to ensure that compensation is competitive, equitable, and aligned with the value each TScanner brings to the role.

Recruitment & Staffing Agencies

TScan Therapeutics does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to TScan Therapeutics or its employees is strictly prohibited unless contacted directly by TScan Therapeutics' internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of TScan Therapeutics, and TScan Therapeutics will not owe any referral or other fees with respect thereto.